Retinal iron homeostasis in health and disease

Frontiers in Aging Neuroscience

Volumn 5, Issue JUN, 2013, Pages

  Song, Delu ^a   Dunaief, Joshua L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Age related macular degeneration (AMD); Ceruloplasmin; Chelator; Ferroportin; Hephaestin; Iron; Oxidative stress; Retina

Indexed keywords

CERULOPLASMIN; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; FERRITIN; FERROPORTIN; FERROUS ION; GUANINE NUCLEOTIDE BINDING PROTEIN; HEPCIDIN; HEPHAESTIN; IRON; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; TRANSFERRIN;

ARTICLE; BLOOD RETINA BARRIER; ENDOSOME; EPITHELIUM CELL; FRIEDREICH ATAXIA; HUMAN; IRON CHELATION; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; NONHUMAN; PH; PIGMENT EPITHELIUM; RETINA; RETINA DEGENERATION; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; SIDEROSIS; TIGHT JUNCTION; YERSINIOSIS;

EID: 84883495401     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2013.00024     Document Type: Article

References (128)

1. Abboud, S., and Haile, D. J. (2000). A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem. 275, 19906-19912. doi: 10.1074/jbc.M000713200
2. Aisen, P., Enns, C., and Wessling-Resnick, M. (2001). Chemistry and biology of eukaryotic iron metabolism. Int. J. Biochem. Cell Biol. 33, 940-959. doi: 10.1016/S1357-2725(01)00063-2
3. AREDS. (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol. 119, 1417-1436.
4. Baker, E., and Morgan, E. H. (1994). "Iron transport," in Iron Metabolism in Health And Disease, eds J. Brock, J. H. Halliday, M. H. Pippard, and L. W. Powell (Philadelphia, PA: W. B. Saunders), 63-95.
5. Beatty, S., Koh, H., Phil, M., Henson, D., and Boulton, M. (2000). The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 45, 115-134. doi: 10.1016/S0039-6257(00)00140-5
6. Bhisitkul, R. B., Winn, B. J., Lee, O.-T., Wong, J., Pereira Dde, S., Porco, T. C., et al. (2008). Neuroprotective effect of intravitreal triamcinolone acetonide against photoreceptor apoptosis in a rabbit model of subretinal hemorrhage. Invest. Ophthalmol. Vis. Sci. 49, 4071-4077. doi: 10.1167/iovs.08-1892
7. Binder, R., Horowitz, J. A., Basilion, J. P., Koeller, D. M., Klausner, R. D., and Harford, J. B. (1994). Evidence that the pathway of transferrin receptor mRNA degradation involves an endonucleolytic cleavage within the 3' UTR and does not involve poly(A) tail shortening. EMBO J. 13, 1969-1980.
8. Brill, P. W., Winchester, P., Giardina, P. J., and Cunningham-Rundles, S. (1991). Deferoxamine-induced bone dysplasia in patients with thalassemia major. AJR Am. J. Roentgenol. 156, 561-565. doi: 10.2214/ajr.156.3.1899759
9. Burdo, J. R., Martin, J., Menzies, S. L., Dolan, K. G., Romano, M. A., Fletcher, R. J., et al. (1999). Cellular distribution of iron in the brain of the Belgrade rat. Neuroscience 93, 1189-1196. doi: 10.1016/S0306-4522(99)00207-9
10. Burdo, J. R., Menzies, S. L., Simpson, I. A., Garrick, L. M., Garrick, M. D., Dolan, K. G., et al. (2001). Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J. Neurosci. Res. 66, 1198-1207. doi: 10.1002/jnr.1256
11. Cheah, J. H., Kim, S. F., Hester, L. D., Clancy, K. W., Patterson, S. E., Papadopoulos, V., et al. (2006). NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase dexras1. Neuron 51, 431-440. doi: 10.1016/j.neuron.2006.07.011
12. Chen, H., Attieh, Z. K., Syed, B. A., Kuo, Y.-M., Stevens, V., Fuqua, B. K., et al. (2010). Identification of zyklopen, a new member of the vertebrate multicopper ferroxidase family, and characterization in rodents and human cells. J. Nutr. 140, 1728-1735. doi: 10.3945/jn.109.117531
13. Chen, L., Dentchev, T., Wong, R., Hahn, P., Wen, R., Bennett, J., et al. (2003). Increased expression of ceruloplasmin in the retina following photic injury. Mol. Vis. 9, 151-158.
14. Chen, Y., Khan, R. S., Cwanger, A., Song, Y., Steenstra, C., Bang, S., et al. (2013). Dexras1, a small GTPase, is required for glutamate-NMDA neurotoxicity. J. Neurosci. 33, 3582-3587. doi: 10.1523/JNEUROSCI.1497-12.2013
15. Chowers, I., Wong, R., Dentchev, T., Farkas, R. H., Iacovelli, J., Gunatilaka, T. L., et al. (2006). The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 47, 2135-2140. doi: 10.1167/iovs.05-1135
16. Cibis, P. A., Yamashita, T., and Rodriguez, F. (1959). Clinical aspects of ocular siderosis and hemosiderosis. AMA Arch. Ophthalmol. 62, 180-187.
17. Declercq, S. S., Meredith, P. C., and Rosenthal, A. R. (1977). Experimental siderosis in the rabbit: correlation between electroretinography and histopathology. Arch. Ophthalmol. 95, 1051-1058. doi: 10.1001/archopht.1977.04450060138014
18. Dentchev, T., Hahn, P., and Dunaief, J. L. (2005). Strong labeling for iron and the iron-handling proteins ferritin and ferroportin in the photoreceptor layer in age-related macular degeneration. Arch. Ophthalmol. 123, 1745-1746. doi: 10.1001/archopht.123.12.1745
19. De Virgiliis, S., Congia, M., Frau, F., Argiolu, F., Diana, G., Cucca, F., et al. (1988). Deferoxamine-induced growth retardation in patients with thalassemia major. J. Pediatr. 113, 661-669. doi: 10.1016/S0022-3476(88)80375-5
20. Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., et al. (2000). Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776-781. doi: 10.1038/35001596
21. Donovan, A., Lima, C. A., Pinkus, J. L., Pinkus, G. S., Zon, L. I., Robine, S., et al. (2005). The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 1, 191-200. doi: 10.1016/j.cmet.2005.01.003
22. Drayer, B., Burger, P., Hurwitz, B., Dawson, D., and Cain, J. (1987). Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content. AJR Am. J. Roentgenol. 149, 357-363. doi: 10.2214/ajr.149.2.357
23. Duce, J. A., Tsatsanis, A., Cater, M. A., James, S. A., Robb, E., Wikhe, K., et al. (2010). Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142, 857-867. doi: 10.1016/j.cell.2010.08.014
24. Dunaief, J. L., Richa, C., Franks, E. P., Schultze, R. L., Aleman, T. S., Schenck, J. F., et al. (2005). Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload. Ophthalmology 112, 1062-1065. doi: 10.1016/j.ophtha.2004.12.029
25. Ebrahimi, K. H., Hagedoorn, P.-L., and Hagen, W. R. (2012). A synthetic peptide with the putative iron binding motif of amyloid precursor protein (APP) does not catalytically oxidize iron. PLoS ONE 7:e40287. doi: 10.1371/journal.pone.0040287
26. Farkas, R. H., Chowers, I., Hackam, A. S., Kageyama, M., Nickells, R. W., Otteson, D. C., et al. (2004). Increased expression of iron-regulating genes in monkey and human glaucoma. Invest. Ophthalmol. Vis. Sci. 45, 1410-1417. doi: 10.1167/iovs.03-0872
27. Feder, J. N., Penny, D. M., Irrinki, A., Lee, V. K., Lebrón, J. A., Watson, N., et al. (1998). The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl. Acad. Sci. U.S.A. 95, 1472-1477. doi: 10.1073/pnas.95.4.1472
28. Fonseca, A. M., Pereira, C. F., Porto, G., and Arosa, F. A. (2003). Red blood cells upregulate cytoprotective proteins and the labile iron pool in dividing human T cells despite a reduction in oxidative stress. Free Radic. Biol. Med. 35, 1404-1416. doi: 10.1016/j.freeradbiomed.2003.08.011
29. Ganz, T., and Nemeth, E. (2009). Iron sequestration and anemia of inflammation. Semin. Hematol. 46, 387-393. doi: 10.1053/j.seminhematol.2009.06.001
30. Gerhardinger, C., Costa, M. B., Coulombe, M. C., Toth, I., Hoehn, T., and Grosu, P. (2005). Expression of acute-phase response proteins in retinal Müller cells in diabetes. Invest. Ophthalmol. Vis. Sci. 46, 349-357. doi: 10.1167/iovs.04-0860
31. Gillies, A., and Lahav, M. (1983). Absorption of retinal and subretinal hemorrhages. Ann. Ophthalmol. 15, 1068-1074.
32. Glatt, H., and Machemer, R. (1982). Experimental subretinal hemorrhage in rabbits. Am. J. Ophthalmol. 94, 762-773. doi: 10.1016/0002-9394(82)90301-4
33. Gnana-Prakasam, J. P., Martin, P. M., Mysona, B. A., Roon, P., Smith, S. B., and Ganapathy, V. (2008). Hepcidin expression in mouse retina and its regulation via lipopolysaccharide/Toll-like receptor-4 pathway independent of Hfe. Biochem. J. 411, 79-88. doi: 10.1042/BJ20071377
34. Gnana-Prakasam, J. P., Tawfik, A., Romej, M., Ananth, S., Martin, P. M., Smith, S. B., et al. (2012). Iron-mediated retinal degeneration in haemojuvelin-knockout mice. Biochem. J. 441, 599-608. doi: 10.1042/BJ20111148
35. Gnana-Prakasam, J. P., Thangaraju, M., Liu, K., Ha, Y., Martin, P. M., Smith, S. B., et al. (2009a). Absence of iron-regulatory protein Hfe results in hyperproliferation of retinal pigment epithelium: role of cystine/glutamate exchanger. Biochem. J. 424, 243-252. doi: 10.1042/BJ20090424
36. Gnana-Prakasam, J. P., Zhang, M., Martin, P. M., Atherton, S. S., Smith, S. B., and Ganapathy, V. (2009b). Expression of the iron-regulatory protein haemojuvelin in retina and its regulation during cytomegalovirus infection. Biochem. J. 419, 533-543. doi: 10.1042/BJ20082240
37. Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., et al. (1997). Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388, 482-488. doi: 10.1038/41343
38. Hadziahmetovic, M., Song, Y., Ponnuru, P., Iacovelli, J., Hunter, A., Haddad, N., et al. (2011a). Age-dependent retinal iron accumulation and degeneration in hepcidin knockout mice. Invest. Ophthalmol. Vis. Sci. 52, 109-118. doi: 10.1167/iovs.10-6113
39. Hadziahmetovic, M., Song, Y., Wolkow, N., Iacovelli, J., Grieco, S., Lee, J., et al. (2011b). The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration. Invest. Ophthalmol. Vis. Sci. 52, 959-968. doi: 10.1167/iovs.10-6207
40. Hadziahmetovic, M., Song, Y., Wolkow, N., Iacovelli, J., Kautz, L., Roth, M.-P., et al. (2011c). Bmp6 regulates retinal iron homeostasis and has altered expression in age-related macular degeneration. Am. J. Pathol. 179, 335-348. doi: 10.1016/j.ajpath.2011.03.033
41. Hahn, P., Dentchev, T., Qian, Y., Rouault, T., Harris, Z. L., and Dunaief, J. L. (2004a). Immunolocalization and regulation of iron handling proteins ferritin and ferroportin in the retina. Mol. Vis. 10, 598-607.
42. Hahn, P., Qian, Y., Dentchev, T., Chen, L., Beard, J., Harris, Z. L., et al. (2004b). Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 101, 13850-13855.
43. Hahn, P., Milam, A. H., and Dunaief, J. L. (2003). Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane. Arch. Ophthalmol. 121, 1099-1105. doi: 10.1001/archopht.121.8.1099
44. Hahn, P., Ying, G., Beard, J., and Dunaief, J. L. (2006). Iron levels in human retina: sex difference and increase with age. Neuroreport 17, 1803-1806. doi: 10.1097/WNR.0b013e3280107776
45. Haimovici, R., D'Amico, D. J., Gragoudas, E. S., and Sokol, S. (2002). The expanded clinical spectrum of deferoxamine retinopathy. Ophthalmology 109, 164-171.
46. Halliwell, B., and Gutteridge, J. M. (1984). Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219, 1-14.
47. Harris, Z. L., Durley, A. P., Man, T. K., and Gitlin, J. D. (1999). Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc. Natl. Acad. Sci. U.S.A. 96, 10812-10817. doi: 10.1073/pnas.96.19.10812
48. Harris, Z. L., Takahashi, Y., Miyajima, H., Serizawa, M., MacGillivray, R. T., and Gitlin, J. D. (1995). Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc. Natl. Acad. Sci. U.S.A. 92, 2539-2543. doi: 10.1073/pnas.92.7.2539
49. Hawkins, K. N. (1986). Contribution of plasma proteins to the vitreous of the rat. Curr. Eye Res. 5, 655-663. doi: 10.3109/02713688609015133
50. Hentze, M. W., and Kühn, L. C. (1996). Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 93, 8175-8182. doi: 10.1073/pnas.93.16.8175
51. Hunt, R. C., and Davis, A. A. (1992). Release of iron by human retinal pigment epithelial cells. J. Cell. Physiol. 152, 102-110. doi: 10.1002/jcp.1041520114
52. Hunt, R. C., Hunt, D. M., Gaur, N., and Smith, A. (1996). Hemopexin in the human retina: protection of the retina against heme-mediated toxicity. J. Cell. Physiol. 168, 71-80. doi: 10.1002/(SICI)1097-4652(199607)168:1<71::AID-JCP9>3.0.CO;2-5
53. Ito, T., Nakano, M., Yamamoto, Y., Hiramitsu, T., and Mizuno, Y. (1995). Hemoglobin-induced lipid peroxidation in the retina: a possible mechanism for macular degeneration. Arch. Biochem. Biophys. 316 864-872. doi: 10.1006/abbi.1995.1116
54. Jünemann, A. G. M., Stopa, P., Michalke, B., Chaudhri, A., Reulbach, U., Huchzermeyer, C., et al. (2013). Levels of aqueous humor trace elements in patients with non-exsudative age-related macular degeneration: a case-control study. PLoS ONE 8:e56734. doi: 10.1371/journal.pone.0056734
55. Kalinowski, D. S., and Richardson, D. R. (2005). The evolution of iron chelators for the treatment of iron overload disease and cancer. Pharmacol. Rev. 57, 547-583. doi: 10.1124/pr.57.4.2
56. Klein, R., Wang, Q., Klein, B. E., Moss, S. E., and Meuer, S. M. (1995). The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest. Ophthalmol. Vis. Sci. 36, 182-191.
57. Knave, B. (1969). Electroretinography in eyes with retained intraocular metallic foreign bodies. Acta Ophthalmol. Suppl. 100(Suppl), 4-63.
58. Knutson, M. D., Oukka, M., Koss, L. M., Aydemir, F., and Wessling-Resnick, M. (2005). Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc. Natl. Acad. Sci. U.S.A. 102, 1324-1328. doi: 10.1073/pnas.0409409102
59. Koeppen, A. H., and Dickson, A. C. (2001). Iron in the Hallervorden-Spatz syndrome. Pediatr. Neurol. 25, 148-155. doi: 10.1016/S0887-8994(01)00269-7
60. Krause, A., Neitz, S., Mägert, H. J., Schulz, A., Forssmann, W. G., Schulz-Knappe, P., et al. (2000). LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 480, 147-150. doi: 10.1016/S0014-5793(00)01920-7
61. Kuo, Y.-M., Duncan, J. L., Westaway, S. K., Yang, H., Nune, G., Xu, E. Y., et al. (2005). Deficiency of pantothenate kinase 2 (Pank2) in mice leads to retinal degeneration and azoospermia. Hum. Mol. Genet. 14, 49-57. doi: 10.1093/hmg/ddi005
62. Kurz, T., Karlsson, M., Brunk, U. T., Nilsson, S. E., and Frennesson, C. (2009). ARPE-19 retinal pigment epithelial cells are highly resistant to oxidative stress and exercise strict control over their lysosomal redox-active iron. Autophagy 5, 494-501. doi: 10.4161/auto.5.4.7961
63. Laicine, E. M., and Haddad, A. (1994). Transferrin, one of the major vitreous proteins, is produced within the eye. Exp. Eye Res. 59, 441-445. doi: 10.1006/exer.1994.1129
64. Leibowitz, H. M., Krueger, D. E., Maunder, L. R., Milton, R. C., Kini, M. M., Kahn, H. A., et al. (1980). The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv. Ophthalmol. 24, 335-610.
65. Levi, S., Corsi, B., Bosisio, M., Invernizzi, R., Volz, A., Sanford, D., et al. (2001). A human mitochondrial ferritin encoded by an intronless gene. J. Biol. Chem. 276, 24437-24440. doi: 10.1074/jbc.C100141200
66. Levi, S., Santambrogio, P., Cozzi, A., Rovida, E., Corsi, B., Tamborini, E., et al. (1994). The role of the L-chain in ferritin iron incorporation. Studies of homo and heteropolymers. J. Mol. Biol. 238, 649-654. doi: 10.1006/jmbi.1994.1325
67. Levin, L. A., and Geszvain, K. M. (1998). Expression of ceruloplasmin in the retina: induction after optic nerve crush. Invest. Ophthalmol. Vis. Sci. 39, 157-163.
68. LeVine, S. M., and Macklin, W. B. (1990). Iron-enriched oligodendrocytes: a reexamination of their spatial distribution. J. Neurosci. Res. 26, 508-512. doi: 10.1002/jnr.490260415
69. Li, D., Ma, W., Sun, F., Pavlidis, P., and Spector, A. (2004). Cluster analysis of genes with significant change in expression in cells conditioned to survive TBOOH. Exp. Eye Res. 78, 301-308. doi: 10.1016/j.exer.2003.10.016
70. Liu, Z. D., and Hider, R. C. (2002). Design of clinically useful iron(III)-selective chelators. Med. Res. Rev. 22, 26-64. doi: 10.1002/med.1027
71. Luckenbach, M. W., Green, W. R., Miller, N. R., Moser, H. W., Clark, A. W., and Tennekoon, G. (1983). Ocular clinicopathologic correlation of Hallervorden-Spatz syndrome with acanthocytosis and pigmentary retinopathy. Am. J. Ophthalmol. 95, 369-382.
72. Lukinova, N., Iacovelli, J., Dentchev, T., Wolkow, N., Hunter, A., Amado, D., et al. (2009). Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli. Invest. Ophthalmol. Vis. Sci. 50, 1440-1447. doi: 10.1167/iovs.08-2545
73. Martin, P. M., Gnana-Prakasam, J. P., Roon, P., Smith, R. G., Smith, S. B., and Ganapathy, V. (2006). Expression and polarized localization of the hemochromatosis gene product HFE in retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 47, 4238-4244.
74. Maxton, D. G., Bjarnason, I., Reynolds, A. P., Catt, S. D., Peters, T. J., and Menzies, I. S. (1986). Lactulose, 51Cr-labelled ethylen-ediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability. Clin. Sci. 71, 71-80.
75. McGahan, M. C., and Fleisher, L. N. (1986). Antioxidant activity of aqueous and vitreous humor from the inflamed rabbit eye. Curr. Eye Res. 5, 641-645. doi: 10.3109/02713688609015131
76. McKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., et al. (2000). A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 5, 299-309. doi: 10.1016/S1097-2765(00)80425-6
77. Mehta, S., and Dunaief, J. L. (2012). "Studies on retinal and choroidal disorders," in The Role of Iron in Retinal Diseases, ed S. Mehta (New York, NY: Humana Press), 259-275.
78. Miyahara, T., Kikuchi, T., Akimoto, M., Kurokawa, T., Shibuki, H., and Yoshimura, N. (2003). Gene microarray analysis of experimental glaucomatous retina from cynomologous monkey. Invest. Ophthalmol. Vis. Sci. 44, 4347-4356. doi: 10.1167/iovs.02-1032
79. Moiseyev, G., Chen, Y., Takahashi, Y., Wu, B. X., and Ma, J.-X. (2005). RPE65 is the isomerohydrolase in the retinoid visual cycle. Proc. Natl. Acad. Sci. U.S.A. 102, 12413-12418. doi: 10.1073/pnas.0503460102
80. Morris, C. M., Candy, J. M., Oakley, A. E., Bloxham, C. A., and Edwardson, J. A. (1992). Histochemical distribution of non-haem iron in the human brain. Acta Anat. (Basel) 144, 235-257. doi: 10.1159/000147312
81. Muckenthaler, M., Gray, N. K., and Hentze, M. W. (1998). IRP-1 binding to ferritin mRNA prevents the recruitment of the small ribosomal subunit by the cap-binding complex eIF4F. Mol. Cell 2, 383-388. doi: 10.1016/S1097-2765(00)80282-8
82. Nemeth, E., and Ganz, T. (2006). Regulation of iron metabolism by hepcidin. Annu. Rev. Nutr. 26, 323-342. doi: 10.1146/annurev.nutr.26.061505.111303
83. Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., et al. (2004). Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093. doi: 10.1126/science.1104742
84. Newell, F. W., Johnson, R. O. 2nd, and Huttenlocher, P. R. (1979). Pigmentary degeneration of the retina in the Hallervorden-Spatz syndrome. Am. J. Ophthalmol. 88, 467-471.
85. Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., et al. (2002). The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110, 1037-1044.
86. Obolensky, A., Berenshtein, E., Lederman, M., Bulvik, B., Alper-Pinus, R., Yaul, R., et al. (2011). Zinc-desferrioxamine attenuates retinal degeneration in the rd10 mouse model of retinitis pigmentosa. Free Radic. Biol. Med. 51, 1482-1491. doi: 10.1016/j.freeradbiomed.2011.07.014
87. Osaki, S. (1966). Kinetic studies of ferrous ion oxidation with crystalline human ferroxidase (Ceruloplasmin). J. Biol. Chem. 241, 5053-5059.
88. Osaki, S., Johnson, D. A., and Frieden, E. (1966). The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem. 241, 2746-2751.
89. Park, C. H., Valore, E. V., Waring, A. J., and Ganz, T. (2001). Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 276, 7806-7810. doi: 10.1074/jbc.M008922200
90. Patel, B. N., and David, S. (1997). A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J. Biol. Chem. 272, 20185-20190. doi: 10.1074/jbc.272.32.20185
91. Patel, B. N., Dunn, R. J., and David, S. (2000). Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J. Biol. Chem. 275, 4305-4310. doi: 10.1074/jbc.275.6.4305
92. Patel, B. N., Dunn, R. J., Jeong, S. Y., Zhu, Q., Julien, J.-P., and David, S. (2002). Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 22, 6578-6586.
93. Picard, E., Jonet, L., Sergeant, C., Vesvres, M.-H., Behar-Cohen, F., Courtois, Y., et al. (2010). Overexpressed or intraperitoneally injected human transferrin prevents photoreceptor degeneration in rd10 mice. Mol. Vis. 16, 2612-2625.
94. Pietrangelo, A. (2004). The ferroportin disease. Blood Cells Mol. Dis. 32, 131-138. doi: 10.1016/j.bcmd.2003.08.003
95. Pietrangelo, A. (2005). Non-HFE hemochromatosis. Semin. Liver Dis. 25, 450-460. doi: 10.1055/s-2005-923316
96. Pietrangelo, A. (2006). Hereditary hemochromatosis. Biochim. Biophys. Acta 1763, 700-710. doi: 10.1016/j.bbamcr.2006.05.013
97. Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., et al. (2001). A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276, 7811-7819. doi: 10.1074/jbc.M008923200
98. Porter, N., Downes, S. M., Fratter, C., Anslow, P., and Németh, A. H. (2007). Catastrophic visual loss in a patient with Friedreich ataxia. Arch. Ophthalmol. 125, 273-274. doi: 10.1001/archopht.125.2.273
99. Poss, K. D., and Tonegawa, S. (1997). Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. U.S.A. 94, 10919-10924. doi: 10.1073/pnas.94.20.10919
100. Richardson, D. R. (2004). Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions. Ann. N.Y. Acad. Sci. 1012, 326-341. doi: 10.1196/annals.1306.026
101. Rodrigues, M. L., Filho, R. B., Laicine, E. M., and Haddad, A. (1998). Transferrin production by the ciliary body of rabbits: a biochemical and immunocytochemical study. Curr. Eye Res. 17, 694-699. doi: 10.1080/02713689808951245
102. Rogers, B. S., Symons, R. C. A., Komeima, K., Shen, J., Xiao, W., Swaim, M. E., et al. (2007). Differential sensitivity of cones to iron-mediated oxidative damage. Invest. Ophthalmol. Vis. Sci. 48, 438-445. doi: 10.1167/iovs.06-0528
103. Roncagliolo, M., Garrido, M., Walter, T., Peirano, P., and Lozoff, B. (1998). Evidence of altered central nervous system development in infants with iron deficiency anemia at 6 mo: delayed maturation of auditory brainstem responses. Am. J. Clin. Nutr. 68, 683-690.
104. Roth, A. M., and Foos, R. Y. (1972). Ocular pathologic changes in primary hemochromatosis. Arch. Ophthalmol. 87, 507-514. doi: 10.1001/archopht.1972.01000020509003
105. Rouault, T. A., and Cooperman, S. (2006). Brain iron metabolism. Semin. Pediatr. Neurol. 13, 142-148. doi: 10.1016/j.spen.2006.08.002
106. Sarkar, J., Seshadri, V., Tripoulas, N. A., Ketterer, M. E., and Fox, P. L. (2003). Role of ceruloplasmin in macrophage iron efflux during hypoxia. J. Biol. Chem. 278, 44018-44024. doi: 10.1074/jbc.M304926200
107. Shichi, H. (1969). Microsomal electron transfer system of bovine retinal pigment epithelium. Exp. Eye Res. 8, 60-68. doi: 10.1016/S0014-4835(69)80081-3
108. Sipe, D. M., and Murphy, R. F. (1991). Binding to cellular receptors results in increased iron release from transferrin at mildly acidic pH. J. Biol. Chem. 266, 8002-8007.
109. Smith, M. A., Harris, P. L. R., Sayre, L. M., and Perry, G. (1997). Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. U.S.A. 94, 9866-9868. doi: 10.1073/pnas.94.18.9866
110. Sneed, S. R. (1988). Ocular siderosis. Arch. Ophthalmol. 106, 997. doi: 10.1001/archopht.1988.01060140143041
111. Song, D., Song, Y., Hadziahmetovic, M., Zhong, Y., and Dunaief, J. L. (2012). Systemic administration of the iron chelator deferiprone protects against light-induced photoreceptor degeneration in the mouse retina. Free Radic. Biol. Med. 53, 64-71. doi: 10.1016/j.freeradbiomed.2012.04.020
112. Talamo, J. H., Topping, T. M., Maumenee, A. E., and Green, W. R. (1985). Ultrastructural studies of cornea, iris and lens in a case of siderosis bulbi. Ophthalmology 92, 1675-1680.
113. Tenenbein, M., Kowalski, S., Sienko, A., Bowden, D. H., and Adamson, I. Y. (1992). Pulmonary toxic effects of continuous desferrioxamine administration in acute iron poisoning. Lancet 339, 699-701. doi: 10.1016/0140-6736(92)90598-W
114. Tripathi, R. C., Millard, C. B., Tripathi, B. J., Chailertborisuth, N. S., Neely, K. A., and Ernest, J. T. (1990). Aqueous humor of cat contains fibroblast growth factor and transferrin similar to those in man. Exp. Eye Res. 50, 109-112. doi: 10.1016/0014-4835(90)90016-N
115. Ugarte, M., Grime, G. W., Lord, G., Geraki, K., Collingwood, J. F., Finnegan, M. E., et al. (2012). Concentration of various trace elements in the rat retina and their distribution in different structures. Metallomics 4, 1245-1254. doi: 10.1039/c2mt20157g
116. Vulpe, C. D., Kuo, Y. M., Murphy, T. L., Cowley, L., Askwith, C., Libina, N., et al. (1999). Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet. 21, 195-199. doi: 10.1038/5979
117. Wang, D., Wang, L.-H., Zhao, Y., Lu, Y.-P., and Zhu, L. (2010). Hypoxia regulates the ferrous iron uptake and reactive oxygen species level via divalent metal transporter 1 (DMT1) Exon1B by hypoxia-inducible factor-1. IUBMB Life 62, 629-636. doi: 10.1002/iub.363
118. Wigglesworth, J., and Baum, H. (1988). "Iron-dependent enzymes in the brain," in Topics in Neurochemistry and Neuropharmacology, ed M. B. H. Youdim (London: Taylor and Francis), 25-66.
119. Wolkow, N., Song, Y., Wu, T.-D., Qian, J., Guerquin-Kern, J.-L., and Dunaief, J. L. (2011). Aceruloplasminemia: retinal histopathologic manifestations and iron-mediated melanosome degradation. Arch. Ophthalmol. 129, 1466-1474. doi: 10.1001/archophthalmol.2011.309
120. Yamaguchi, K., Takahashi, S., Kawanami, T., Kato, T., and Sasaki, H. (1998). Retinal degeneration in hereditary ceruloplasmin deficiency. Ophthalmologica 212, 11-14. doi: 10.1159/000027251
121. Yefimova, M. G., Jeanny, J. C., Guillonneau, X., Keller, N., Nguyen-Legros, J., Sergeant, C., et al. (2000). Iron, ferritin, transferrin, and transferrin receptor in the adult rat retina. Invest. Ophthalmol. Vis. Sci. 41, 2343-2351.
122. Yefimova, M. G., Jeanny, J.-C., Keller, N., Sergeant, C., Guillonneau, X., Beaumont, C., et al. (2002). Impaired retinal iron homeostasis associated with defective phagocytosis in Royal College of Surgeons rats. Invest. Ophthalmol. Vis. Sci. 43, 537-545.
123. Youdim, M. (1990). "Neuropharmacological and neurobiochemical aspects of iron deficiency," in Brain, Behavior, and Iron in the Infant Diet, ed J. Dobbing (London: Springer), 83-106.
124. Youssef, T., Trese, M., Hartzer, M., Mahgoub, M., Raza, H., Azrak, M., et al. (2002). Deferoxamine reduces retinal toxicity from subretinal blood. Invest. Ophthalmol. Vis. Sci. 43, 3000.
125. Yu, T. C., and Okamura, R. (1988). Quantitative study of characteristic aqueous humor transferrin, serum transferrin and desialized serum transferrin in aqueous humor. Jpn. J. Ophthalmol. 32, 268-274.
126. Zarbin, M. A. (2004). Current concepts in the pathogenesis of age-related macular degeneration. Arch. Ophthalmol. 122, 598-614. doi: 10.1001/archopht.122.4.598
127. Zheng, H., Weiner, L. M., Bar-Am, O., Epsztejn, S., Cabantchik, Z. I., Warshawsky, A., et al. (2005). Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases. Bioorg. Med. Chem. 13, 773-783. doi: 10.1016/j.bmc.2004.10.037
128. Zhou, B., Westaway, S. K., Levinson, B., Johnson, M. A., Gitschier, J., and Hayflick, S. J. (2001). A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat. Genet. 28, 345-349. doi: 10.1038/ng572